Ventricular Arrhythmias Following Ibrutinib Initiation for Lymphoid Malignancies

J Am Coll Cardiol. 2018 Aug 7;72(6):697-698. doi: 10.1016/j.jacc.2018.06.002.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives
  • Agammaglobulinaemia Tyrosine Kinase / antagonists & inhibitors*
  • Aged
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Lymphoma / diagnosis
  • Lymphoma / drug therapy*
  • Lymphoma / epidemiology
  • Male
  • Middle Aged
  • Piperidines
  • Protein Kinase Inhibitors / adverse effects*
  • Pyrazoles / adverse effects*
  • Pyrimidines / adverse effects*
  • Ventricular Fibrillation / chemically induced*
  • Ventricular Fibrillation / diagnosis
  • Ventricular Fibrillation / epidemiology

Substances

  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • ibrutinib
  • Agammaglobulinaemia Tyrosine Kinase
  • BTK protein, human
  • Adenine